Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Efficacy of iTBS Targeting NAc and sgACC in Regulating the Reward Circuit Function to Improve Anhedonia in Depression

NCT07813169 is registered in ClinicalTrials.gov with Guo Wenbin as lead sponsor.

NCT NCT07813169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07813169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Efficacy of iTBS Targeting NAc and sgACC in Regulating the Reward Circuit Function to Improve Anhedonia in Depression
Lead sponsor
Guo Wenbin
Phase
Not applicable
Overall status
Recruiting
Start date
May 19, 2026
Completion date
July 3, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, major depression, melancholic depression, theta burst stimulation